Veev fundamental analysis

**Veeva Systems Inc. (VEEV) exhibits strong fundamentals that support its position as a leading provider of cloud-based software solutions for the life sciences industry.** The company's robust growth in revenue, net income, and diluted EPS, along with its strategic partnerships and innovative product offerings, underscore its potential for continued growth and profitability. However, rising operational costs and the competitive CRM market present challenges that investors should be aware of. 1. **Financial Performance and Growth**: - Veeva's recent financials show impressive growth rates: a 16.71% increase in total revenue to $759.04 million, a 41.15% rise in net income to $228.19 million, and a 39.8% growth in diluted EPS to $1.37. - The company's compounded annual growth rates (CAGRs) for revenue, net income, and diluted EPS over the past five years are 17.01%, 17.08%, and 16.32%, respectively, indicating consistent and stable growth. |code|Ticker|Name|Date|Net Income YoY|Total Revenue YoY|Diluted EPS YoY|market_code| |---|---|---|---|---|---|---|---| |VEEV|VEEV.N|Veeva Systems|2025 Q2|53.22410147991543|14.563259773815071|52.941176470588225|169| |VEEV|VEEV.N|Veeva Systems|2025 Q3|37.474659287648535|13.414651949294814|36.14457831325301|169| |VEEV|VEEV.N|Veeva Systems|2025 Q4|32.718897135646344|14.314212407511363|31.1111111111111|169| |VEEV|VEEV.N|Veeva Systems|2026 Q1|41.1507818685669|16.71389800798038|39.79591836734695|169| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |VEEV|VEEV.N|Veeva Systems|2025 Q2|14.563259773815071|6.76181E8|169| |VEEV|VEEV.N|Veeva Systems|2025 Q3|13.414651949294814|6.99207E8|169| |VEEV|VEEV.N|Veeva Systems|2025 Q4|14.314212407511363|7.20886E8|169| |VEEV|VEEV.N|Veeva Systems|2026 Q1|16.71389800798038|7.59043E8|169| |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |VEEV|VEEV.N|Veeva Systems|2025 Q2|53.22410147991543|1.71041E8|169| |VEEV|VEEV.N|Veeva Systems|2025 Q3|37.474659287648535|1.85808E8|169| |VEEV|VEEV.N|Veeva Systems|2025 Q4|32.718897135646344|1.95625E8|169| |VEEV|VEEV.N|Veeva Systems|2026 Q1|41.1507818685669|2.2819E8|169| |code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code| |---|---|---|---|---|---|---| |VEEV|VEEV.N|Veeva Systems|2025 Q2|52.941176470588225|1.04|169| |VEEV|VEEV.N|Veeva Systems|2025 Q3|36.14457831325301|1.13|169| |VEEV|VEEV.N|Veeva Systems|2025 Q4|31.1111111111111|1.18|169| |VEEV|VEEV.N|Veeva Systems|2026 Q1|39.79591836734695|1.37|169| 2. **Valuation Metrics**: - Veeva's P/E ratio stands at 58.74, indicating a premium valuation compared to the industry average. - The P/S ratio is 16.06, and the Price to Book ratio is 7.38, suggesting that the market values the company's growth prospects. |code|Ticker|Name|Date|P/E(TTM)|P/S|Price to Book Ratio|market_code| |---|---|---|---|---|---|---|---| |VEEV|VEEV.N|Veeva Systems|20240819|56.500508|11.850649048100076|6.423245560458471|169| |VEEV|VEEV.N|Veeva Systems|20240820|56.323108|11.813440401202088|6.403077865421001|169| |VEEV|VEEV.N|Veeva Systems|20240821|58.582779|12.287393165787929|6.659968013685168|169| |VEEV|VEEV.N|Veeva Systems|20240822|57.308988|12.020222881504019|6.515157350957105|169| |VEEV|VEEV.N|Veeva Systems|20240823|57.945884|12.153808023645974|6.587562682321137|169| |VEEV|VEEV.N|Veeva Systems|20240826|57.823739|12.128188955289982|6.573676728360911|169| |VEEV|VEEV.N|Veeva Systems|20240827|58.236704|12.214805805445954|6.6206244774645295|169| |VEEV|VEEV.N|Veeva Systems|20240828|57.974966|12.159907801825973|6.590868861835475|169| |VEEV|VEEV.N|Veeva Systems|20240829|63.113755|13.237738606231614|7.175070782019238|169| |VEEV|VEEV.N|Veeva Systems|20240830|62.945079|13.202359892787626|7.1558949408360695|169| 3. **Dividend and Cash Flow**: - Veeva does not currently pay dividends, which is consistent with its history and focus on reinvestment for growth. - The company's free cash flow stands at $871.25 million, indicating a strong capacity to fund operations and growth initiatives. |code|Ticker|Name|Date|Payout Ratio|Dividend Yield (TTM)|market_code| |---|---|---|---|---|---|---| |VEEV|VEEV.N|Veeva Systems||||169| |code|Ticker|Name|Date|Free Cash Flow|Investing Cash Flow|Operating Cash Flow|Financing Cash Flow|market_code| |---|---|---|---|---|---|---|---|---| |VEEV|VEEV.N|Veeva Systems|2025 Q2|-5.9690999858E8|-1.13842E8|9.2874E7|-1.1484E7|169| |VEEV|VEEV.N|Veeva Systems|2025 Q3|-4.78978821729E8|-2.98226E8|1.64117E8|1.296E7|169| |VEEV|VEEV.N|Veeva Systems|2025 Q4|-3.5306761444E8|-1.5692E7|6.9544E7|2.0811E7|169| |VEEV|VEEV.N|Veeva Systems|2026 Q1|-9.93114124486E8||||169| 4. **Strategic Positioning and Growth Drivers**: - Veeva's strategic partnerships, such as with Merck and Walgreens Boots Alliance, are expected to drive growth and market expansion. - The company's innovative product offerings, including AI-driven tools and its Vault CRM, are enhancing efficiency and compliance in the life sciences industry. - The eClinical Solutions Market is projected to grow significantly, which could benefit Veeva's solutions and market position. 5. **Market Challenges and Risks**: - Operational costs are increasing, which could impact profitability if not managed effectively. - The company faces competition in the CRM market, particularly from Salesforce, although it has successfully transitioned to its own Vault platform. 6. **Financial Health and Growth Prospects**: - Veeva's return on equity (ROE) is higher than the industry average, indicating efficient profit generation. - Analysts have a "Moderate Buy" consensus rating with an average price target of $274.17, suggesting potential for further stock price appreciation. - The company's financial outlook includes expectations of continued revenue and earnings growth, with some analysts projecting $4.1 billion in revenue and $1.2 billion in earnings by 2028. In conclusion, Veeva Systems demonstrates strong growth potential and a solid financial foundation, supported by its strategic positioning and innovative product offerings. However, investors should consider the premium valuation and rising operational costs when assessing the company's risk profile. The absence of dividends may also be a consideration for income-focused investors.